CION Ameerpet
Immunotherapy Side Effects · Steroids & Immune Reactions
Do Steroids Reduce Immunotherapy's Effectiveness? — Here's What the Evidence Says
Many patients prescribed steroids for an immune reaction quietly worry the medicine will undo the benefit of their immunotherapy. The honest answer is nuanced: the timing of steroid use matters far more than the fact that steroids were used at all. NCCN and ASCO guidance on managing immune-related adverse events treats a properly managed steroid course as standard care, not a compromise on effectiveness.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Timing is what matters — steroids given to treat a genuine reaction after immunotherapy has started don't meaningfully reduce its benefit in most published data.
- Starting on steroids is different — beginning immunotherapy while already on higher-dose steroids for an unrelated reason is the pattern most linked to reduced benefit in studies.
- Untreated reactions cause more harm — leaving a moderate-to-severe reaction untreated to "protect" the treatment risks stopping immunotherapy altogether.
- Never decide this alone — dose, duration, and tapering are individualised calls your oncology team makes with you, not something to self-manage out of fear.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Answer this first
Should Steroid Treatment Be Delayed Over This Question?
No. If your oncology team has prescribed steroids for a moderate-to-severe immune reaction, take them as directed — don't skip or delay a dose out of fear it will undo your immunotherapy's benefit. An untreated reaction is far more likely to end your immunotherapy course altogether than a properly managed steroid course is to weaken it.
Go to the ER now, or call an ambulance, if you have any of these right now:
- Severe breathlessness, chest pain, or a racing/irregular heartbeat
- Six or more loose stools a day, or blood in the stool
- Confusion, extreme drowsiness, or fainting
- Yellowing of the skin or eyes, or dark urine
- Any symptom your care team has told you to treat as an emergency
For any other question about a steroid course you've already been prescribed, call the CION helpline the same day:
Call the CION Helpline Now: 1800 202 8726
The core question
Do Steroids Cancel Out the Immunotherapy Benefit?
Not in the way many patients fear. Published research shows that steroids given to treat an immune-related side effect after immunotherapy has already started do not meaningfully reduce its effectiveness for most patients. The clearer link to reduced benefit is with higher-dose steroids used before immunotherapy begins, for a reason unrelated to the cancer treatment itself.
This distinction matters because the two situations look similar from the outside — "a patient on steroids while on immunotherapy" — but they reflect very different circumstances. NCCN and ASCO guidance on immune-related adverse events (updated 2024-25) treats steroid treatment for a genuine reaction as standard practice precisely because the risk of leaving a significant reaction unmanaged is considered greater than the theoretical risk to effectiveness. Evidence in this area continues to evolve, and individual factors — the type of cancer, how the treatment was already working before the reaction, and the dose and duration of steroids — all play a role your oncology team accounts for.
Timing, not the drug
Does the Timing of Steroid Use Matter?
Yes — timing is the single biggest factor. Steroids started before immunotherapy begins, particularly at higher doses for an unrelated condition, are associated with poorer outcomes in observational studies. Steroids started after treatment is already under way, to manage a side effect, have not shown that same pattern in most research published to date.
| Scenario | What research generally shows | Practical takeaway |
|---|---|---|
| Steroids started before immunotherapy begins, for an unrelated condition | Associated with reduced treatment benefit in several observational studies, particularly at higher doses | Your oncologist may factor this into the treatment plan or its timing |
| Steroids used for a mild reaction (grade 1) | Often managed without steroids, or with a low-dose/topical approach; effectiveness data not typically affected | Managed per your care team's standard protocol |
| Steroids used for a moderate-to-severe reaction (grade 2 and above) | Current research does not show a consistent reduction in effectiveness when steroids are used at this stage | Treating the reaction promptly is the priority |
| Long-term, low-dose steroid use for an unrelated chronic condition | Less well studied; effects likely depend on dose and duration | Flag it clearly with your oncology team before immunotherapy starts |
"Grade" here refers to how a reaction's severity is classified by your care team, not a dose or drug name — your oncologist will always explain what grade applies to your specific situation.
Weighing the decision
Should Steroids Be Avoided During Immunotherapy?
No, not when your care team has recommended them to manage a genuine immune-related reaction. Avoiding a needed steroid course out of fear can allow a treatable reaction to worsen, sometimes forcing immunotherapy to be paused or stopped altogether — an outcome that affects your treatment far more than a properly managed, tapered steroid course would.
This is a decision made jointly with your oncology team, on a case-by-case basis. Never start, stop, adjust, or skip a steroid dose on your own — including because of something you've read about effectiveness, this page included. If a dose change ever feels right to you, raise it with your team rather than acting on it yourself.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Steroids and Immunotherapy Don't Have to Be an Either/Or Decision
Our oncology team can walk you through exactly how a steroid course fits your specific treatment plan.
The bigger risk
Why Do Guidelines Treat the Reaction as the Priority?
Because an unmanaged moderate-to-severe immune reaction can damage organs, require hospital admission, and often forces immunotherapy to be permanently discontinued — a far larger interruption to treatment than a properly tapered steroid course. Guidelines are written around minimising that bigger risk first.
- 1
The reaction is identified and graded
Your care team assesses how severe it is using standard criteria, which determines whether steroids are needed at all.
- 2
Steroids are started if the grade calls for them
A course is chosen based on severity — mild reactions are often managed without steroids or with a limited local approach.
- 3
Immunotherapy is usually paused, not stopped
Most reactions allow treatment to resume once the reaction is controlled — permanent discontinuation is reserved for the most severe or recurrent cases.
- 4
The steroid dose is reduced gradually
Rather than stopped abruptly, the dose is tapered down over time as the reaction settles, under your team's supervision.
- 5
Your response is reviewed before restarting
Your oncologist checks that the reaction has settled and reassesses your overall treatment plan before immunotherapy resumes.
What actually happens to the dose
Why Is the Steroid Dose Reduced Slowly Instead of Stopped?
Steroid courses for immune reactions are almost always tapered — the dose is brought down gradually over a period your endocrine or oncology team sets, rather than stopped suddenly. This protects against a rebound flare of the original reaction and against the body's own hormone system needing time to recover its normal function. Our companion page, Why the Steroid Dose Is Reduced Slowly (Tapering), walks through what that process generally looks like.
Care during treatment
Every Steroid Decision Is Made With Your Oncology Team
Patients who report reactions early are supported by the same multidisciplinary team throughout treatment.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Steroids and Immunotherapy Effectiveness: Your Questions Answered
Do steroids cancel out the immunotherapy benefit?
Not in the way many patients fear. Published research shows that steroids given to treat an immune-related side effect after immunotherapy has already started do not meaningfully reduce its effectiveness for most patients. The clearer link to reduced benefit is with higher-dose steroids used before immunotherapy begins, for an unrelated reason — that pattern, not steroid use for a reaction, is what the evidence points to.
Does the timing of steroid use matter?
Yes, timing is the single biggest factor. Steroids started before immunotherapy begins, particularly at higher doses for an unrelated condition, are associated with poorer outcomes in observational studies. Steroids started after treatment is already under way, to manage a genuine immune reaction, have not shown that same pattern in most research published to date.
Should steroids be avoided during immunotherapy?
No, not when your care team has recommended them to manage a genuine immune-related reaction. Avoiding a needed steroid course out of fear can allow a treatable reaction to worsen, sometimes forcing immunotherapy to be paused or stopped altogether — which affects your outcome far more than a properly managed, tapered steroid course ever would.
What's the difference between steroids started before treatment and steroids used to treat a side effect?
Steroids started before immunotherapy begins are usually being taken for an unrelated health condition and reflect a different immune state going into treatment — this is the pattern linked to reduced benefit in studies. Steroids started after immunotherapy begins are a direct response to a side effect the treatment itself has caused, at a point when the immune system has typically already been reactivated against the cancer.
What do oncology guidelines actually say about this?
NCCN and ASCO guidance on managing immune-related adverse events, most recently updated in 2024-25, recommends steroids as standard treatment for moderate-to-severe reactions despite this same question having been studied — because leaving a significant reaction untreated is considered a bigger risk to the overall treatment course than the steroid itself.
Can refusing steroids for a severe reaction hurt my treatment more than taking them?
Yes, in most cases. An unmanaged moderate-to-severe immune reaction can damage organs, require hospitalisation, and often forces immunotherapy to be permanently discontinued — a far larger interruption to your treatment than a properly tapered steroid course. This is why oncology teams treat the reaction first and address the effectiveness question separately, with you, afterwards.